<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03702400</url>
  </required_header>
  <id_info>
    <org_study_id>000.603</org_study_id>
    <nct_id>NCT03702400</nct_id>
  </id_info>
  <brief_title>Norepinephrine or Phenylephrine in Bolus for Hypotension in Cesarean Delivery</brief_title>
  <official_title>Randomized Double-blinded Comparison of Norepinephrine and Phenylephrine in Bolus for Maintenance of Blood Pressure During Spinal Anesthesia for Cesarean Delivery</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hospital dos Servidores do Estado do Rio de Janeiro</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Hospital dos Servidores do Estado do Rio de Janeiro</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>Yes</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>Yes</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study evaluate the ability of phenylephrine and of noradrenaline to maintain normal
      systemic arterial blood pressure and heart rate in healthy pregnant women submitted to
      cesarean section with spinal anesthesia. Half of participants will receive bolus of
      phenylephrine while the other half will receive bolus of noradrenaline.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This is a prospective, randomized, double-blind, comparative two-group clinical study to
      observe two vasopressor drugs, phenylephrine and noradrenaline, in the ability to maintain
      systemic arterial pressure in pregnant women after spinal anesthesia for cesarean section;
      based on the hypothesis that, since noradrenaline has a predominant alpha-adrenergic action
      and a weak 1- beta-adrenergic beta action, it could be as capable of maintaining blood
      pressure effectively as phenylephrine, but with a lower frequency of bradycardia; patients
      who meet the inclusion criteria will be randomly assigned to one of the groups to be studied:
      group F - phenylephrine at a dose of 100mcg bolus and N - noradrenaline at the dose of 5mcg.
      One of these drugs will be used whenever systolic blood pressure drops below 10% of the
      baseline, additional doses will be allowed whenever necessary, aiming at maintaining the
      systolic blood pressure at baseline values; the blood pressure will be measured
      non-invasively and the heart rate by pulse oximeter and electrocardiogram.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">October 1, 2018</start_date>
  <completion_date type="Anticipated">October 1, 2020</completion_date>
  <primary_completion_date type="Anticipated">June 1, 2020</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>In a randomized, double-blinded study, 76 healthy patients having cesarean delivery under spinal anesthesia will be randomized, using an electronic system (the Randomizer AppÂ®, Version 3.2 Wisse Keizer program), to have systolic blood pressure maintained with bolus of phenylephrine at a dose of 100 mcg bolus (at a dilution containing 20 mcg / mL), or with norepinephrine at a dose of 5 mcg (at a dilution containing 1 mcg / mL).</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Care Provider, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Number of bolus required</measure>
    <time_frame>during the procedure</time_frame>
    <description>Number of bolus doses of phenylephrine and noradrenaline to maintain systemic arterial pressure at 90% of baseline in pregnant women undergoing spinal anesthesia for cesarean</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Heart rate</measure>
    <time_frame>during the procedure</time_frame>
    <description>Number of episodes of heart rate under 60 bpm while using phenylephrine and noradrenaline in pregnant women undergoing spinal anesthesia for cesarean</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Neonatal outcome</measure>
    <time_frame>during the procedure</time_frame>
    <description>To evaluate the neonatal outcome through the analysis of venous and arterial blood gases collected in the cord umbilical after birth.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Neonatal outcome</measure>
    <time_frame>during the procedure</time_frame>
    <description>To evaluate the neonatal outcome through the classification given by the neonatologist responsible for the care to the newborn in the delivery room with the use of the Apgar Scale.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Nausea and vomiting</measure>
    <time_frame>during the procedure</time_frame>
    <description>To evaluate the incidence of nausea and vomiting of the parturient during cesarean section</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">76</enrollment>
  <condition>Hypotension</condition>
  <condition>Spinal Anesthesia</condition>
  <arm_group>
    <arm_group_label>Phenylephrine 100 mcg</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Phenylephrine will be used at a dose of 100 mcg bolus at a dilution containing 20 mcg / mL of the drug to be used whenever systolic blood pressure falls below 10% of baseline.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Norepinephrine 5 mcg</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Norepinephrine will be used at a dose of 5 mcg at a dilution containing 1 mcg / mL to be used whenever systolic blood pressure falls below 10% of baseline.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Phenylephrine 100 mcg</intervention_name>
    <description>Phenylephrine at a dose of 100 mcg bolus at a dilution containing 20 mcg / mL of the drug, 5 mL each bolus</description>
    <arm_group_label>Phenylephrine 100 mcg</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Norepinephrine 5 mcg</intervention_name>
    <description>Norepinephrine at a dose of 5 mcg at dilution containing 1 mcg / mL, 5 mL each bolus</description>
    <arm_group_label>Norepinephrine 5 mcg</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Pregnant women, with single gestation, with cesarean programming to be performed under
             spinal anesthesia;

          -  Age above 18 years;

          -  Physical State American Society of Anesthesiologists (ASA) II and III;

          -  Weight between 50kg and 120kg;

          -  Height between 140cm and 180cm.

        Exclusion Criteria:

          -  Refusal to participate in the study;

          -  Pregnant women with fetus with known abnormalities;

          -  Pregnant women with cardiovascular disease;

          -  Pregnant women with pregnancy-specific hypertensive disease;

          -  Allergy to any medication to be used in the study;

          -  Users of monoamine oxidase inhibitors;

          -  Users of tricyclic antidepressants;

          -  Emergency caesarean section due to acute fetal distress;

          -  Situations in which the sensory level after single intrathecal injection of the local
             anesthetic does not reach at least T6 within 5 minutes after spinal anesthesia.
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>DANIEL V DE QUEIROZ</last_name>
    <role>Principal Investigator</role>
    <affiliation>HOSPITAL FEDERAL DOS SERVIDORES DO ESTADO</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>DANIEL V DE QUEIROZ</last_name>
    <phone>5521992863032</phone>
    <email>queirozdaniel@globo.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>ROBERTA B LAMELLA</last_name>
    <phone>55212291-3131</phone>
    <email>cep-hse@hse.rj.saude.gov.br</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Hospital Federal Dos Servidores Do Estado</name>
      <address>
        <city>Rio De Janeiro</city>
        <state>RJ</state>
        <zip>22451-030</zip>
        <country>Brazil</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>DANIEL V DE QUEIROZ</last_name>
      <phone>21992863032</phone>
      <email>queirozdaniel@globo.com</email>
    </contact>
  </location>
  <location_countries>
    <country>Brazil</country>
  </location_countries>
  <results_reference>
    <citation>Ngan Kee WD, Lee SW, Ng FF, Tan PE, Khaw KS. Randomized double-blinded comparison of norepinephrine and phenylephrine for maintenance of blood pressure during spinal anesthesia for cesarean delivery. Anesthesiology. 2015 Apr;122(4):736-45. doi: 10.1097/ALN.0000000000000601.</citation>
    <PMID>25635593</PMID>
  </results_reference>
  <results_reference>
    <citation>Vallejo MC, Attaallah AF, Elzamzamy OM, Cifarelli DT, Phelps AL, Hobbs GR, Shapiro RE, Ranganathan P. An open-label randomized controlled clinical trial for comparison of continuous phenylephrine versus norepinephrine infusion in prevention of spinal hypotension during cesarean delivery. Int J Obstet Anesth. 2017 Feb;29:18-25. doi: 10.1016/j.ijoa.2016.08.005. Epub 2016 Aug 28.</citation>
    <PMID>27720613</PMID>
  </results_reference>
  <verification_date>October 2018</verification_date>
  <study_first_submitted>October 6, 2018</study_first_submitted>
  <study_first_submitted_qc>October 8, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">October 11, 2018</study_first_posted>
  <last_update_submitted>October 8, 2018</last_update_submitted>
  <last_update_submitted_qc>October 8, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">October 11, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Hospital dos Servidores do Estado do Rio de Janeiro</investigator_affiliation>
    <investigator_full_name>DANIEL VIEIRA DE QUEIROZ</investigator_full_name>
    <investigator_title>Department Chair</investigator_title>
  </responsible_party>
  <keyword>phenylephrine</keyword>
  <keyword>norepinephrine</keyword>
  <keyword>cesarean delivery under spinal anesthesia</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hypotension</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Phenylephrine</mesh_term>
    <mesh_term>Oxymetazoline</mesh_term>
    <mesh_term>Norepinephrine</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

